Aardvark Therapeutics, a US biotech group developing a weight loss pill, is planning to raise up to $200mn in an initial public offering
https://www.ft.com/content/e3c4130d-494d-4f69-b5fe-81833f88caed
Aardvark Therapeutics, a US biotech group developing a weight loss pill, is planning to raise up to $200mn in an initial public offering
https://www.ft.com/content/e3c4130d-494d-4f69-b5fe-81833f88caed
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.